A new study found no significant benefit in adding low-dose oral glucocorticoids to immunosuppressive therapy for improving skin fibrosis in patients with early diffuse cutaneous systemic ...

A father of three is using being busy as a weapon in his fight against a rare autoimmune disease that has no cure.

Cabaletta’s new data slice for its investigational CD19-CAR T cell therapy shows “robust benefit” for patients with lupus and ...

An expert review provides best practice advice on diagnostic considerations of immune-mediated disorders that should be ...

She has severe fatigue, arthralgias, and tight, itchy skin on her face ... a nearby university medical department who diagnoses systemic sclerosis. She and her husband are frightened, especially ...

A woman dubbed 'the world's most beautiful traffic warden' has shared a horrible health battle she has had to go through ...

Specialty pharmaceutical companies Cumberland Pharmaceuticals Inc. and SciClone Pharmaceuticals (Holdings) Limited ("SciClone Pharmaceuticals" or "SciClone") today announced the NMPA (National Medical ...

Peptide therapy enhances targeted medicine, utilizing specific peptides for effective treatment of cancer, metabolic disorders, and neurodegenerative diseases.

Among the total systemic sclerosis cohort, 14% of individuals were categorized as frail and 53% as prefrail, with frailty status linked to an increased risk for mortality.

The following is a summary of “Cross-trait GWAS in COVID-19 and systemic sclerosis reveals novel genes implicated in fibrotic ...

The following is a summary of “Foot peripheral sensory neuropathy: a frequent disabling manifestation in systemic sclerosis,” ...